BMY Stock Holds Steady Amid Dividend Declaration and Opdivo Lawsuit

Bristol Myers Squibb's stock price has held steady at $63.69 per share, despite a 0.64% decline from its prior close on September 15, 2026.

The company's Board of Directors declared a quarterly dividend of $0.63 per share, payable to shareholders on November 2, 2026.

This move supports the income profile for investors, with the forward dividend yield standing at around 3.95% based on the current share price.

A lawsuit filed by Bristol Myers Squibb and its partner Ono Pharmaceutical against Amgen aims to block a proposed U.S. biosimilar version of Opdivo, which could impact the company's immuno-oncology franchise.